Episode Details
Back to Episodes
Sunzen Still Turning Things Around
Published 2 years, 4 months ago
Description
It was announced that Sunzen Biotech will be exiting from its animal health business to focus on human health products and loan financing services. Executive chairman, Ching Chee Pun shares with us the rationale behind this decision, the outlook and why they appear to have a weak track record when it comes to M&A.
See omnystudio.com/listener for privacy information.